In summary, mesoporous Fe3O4-containing GOD-conjugated GPC3 peptide nanoparticles (FGP NPs) can bind to the membrane protein GPC3, which is expressed on the surface of HCC cells, and trigger a series of catalytic reactions in the TME. Here, GPC3 is linked to hepatocellular carcinoma.